Staphlyococcus aureus phenol-soluble modulins stimulate the release of proinflammatory cytokines from keratinocytes and are required for induction of skin inflammation

Infection and Immunity

Volumn 83, Issue 9, 2015, Pages 3428-3437

  Syed, Adnan K ^a,b   Reed, Tamra J ^c   Clark, Kaitlyn L ^c   Boles, Blaise R ^b   Kahlenberg, J Michelle ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BACTERIAL PROTEIN; BETA ACTIN; BETA INTERFERON; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CHEMOKINE RECEPTOR CCR1; CRYOPYRIN; CXCL13 CHEMOKINE; CYTOKINE; CYTOTOXIC FACTOR; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PHENOL; PHENOL SOLUBLE MODULIN PEPTIDE; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BACTERIAL TOXIN; STAPHYLOCOCCAL DELTA TOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; CYTOKINE RELEASE; DERMATITIS; EPIDERMIS; FEMALE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; MOUSE; NONHUMAN; PRIMARY CELL CULTURE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS CAPITIS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS HOMINIS; STAPHYLOCOCCUS LUGDUNENSIS; STAPHYLOCOCCUS SAPROPHYTICUS; STAPHYLOCOCCUS WARNERI; WILD TYPE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL LINE; DISEASE MODEL; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; STAPHYLOCOCCAL SKIN INFECTION;

ANIMALS; BACTERIAL TOXINS; CELL LINE; CYTOKINES; DERMATITIS; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-18; KERATINOCYTES; MICE; MICE, INBRED C57BL; REAL-TIME POLYMERASE CHAIN REACTION; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84939484873     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00401-15     Document Type: Article

References (47)

1. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK, Active Bacterial Core Surveillance (ABCs) Investigators MRSA. 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:1763-1771. http://dx.doi.org/10.1001/jama.298.15.1763.
2. Kuehnert MJ, Kruszon-Moran D, Hill HA, McQuillan G, McAllister SK, Fosheim G, McDougal LK, Chaitram J, Jensen B, Fridkin SK, Killgore G, Tenover FC. 2006. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis 193:172-179. http://dx.doi.org/10.1086/499632.
3. Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A, Kallen A, Limbago B, Fridkin S, National Healthcare Safety Network (NHSN) Team and Participating Facilities NHSN. 2013. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol 34:1-14. http://dx.doi.org/10.1086/668770.
4. De Benedetto A, Agnihothri R, McGirt LY, Bankova LG, Beck LA. 2009. Atopic dermatitis: a disease caused by innate immune defects? J Investig Dermatol 129:14-30. http://dx.doi.org/10.1038/jid.2008.259.
5. Nutten S. 2015. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab 66(Suppl 1):S8-S16. http://dx.doi.org/10.1159/000370220.
6. Foster TJ, Hook M. 1998. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol 6:484-488. http://dx.doi.org/10.1016/S0966-842X(98)01400-0.
7. Travers JB, Norris DA, Leung DY. 2001. The keratinocyte as a target for staphylococcal bacterial toxins. J Investig Dermatol Symp Proc 6:225-230. http://dx.doi.org/10.1046/j.0022-202x.2001.00045.x.
8. Sasaki T, Kano R, Sato H, Nakamura Y, Watanabe S, Hasegawa A. 2003. Effects of staphylococci on cytokine production from human keratinocytes. Br J Dermatol 148:46-50. http://dx.doi.org/10.1046/j.1365-2133.2003.05017.x.
9. Travers JB, Kozman A, Mousdicas N, Saha C, Landis M, Al-Hassani M, Yao W, Yao Y, Hyatt A-M, Sheehan MP, Haggstrom AN, Kaplan MH. 2010. Infected atopic dermatitis lesions contain pharmacologic amounts of lipoteichoic acid. J Allergy Clin Immunol 125:146-152.e1-2. http://dx.doi.org/10.1016/j.jaci.2009.09.052.
10. Yao Y, Kozman A, Al-Hassani M, Saha CK, Yi Q, Yao W, Mousdicas N, Kaplan MH, Travers JB. 2010. Identification of staphylococcal protein A in infected atopic dermatitis lesions. J Investig Dermatol 130:2502-2504. http://dx.doi.org/10.1038/jid.2010.154.
11. Terada M, Tsutsui H, Imai Y, Yasuda K, Mizutani H, Yamanishi K, Kubo M, Matsui K, Sano H, Nakanishi K. 2006. Contribution of IL-18 to atopic-dermatitis-like skin inflammation induced by Staphylococcus aureus product in mice. Proc Natl Acad Sci U S A 103:8816-8821. http://dx.doi.org/10.1073/pnas.0602900103.
12. Ommori R, Ouji N, Mizuno F, Kita E, Ikada Y, Asada H. 2013. Selective induction of antimicrobial peptides from keratinocytes by staphylococcal bacteria. Microb Pathog 56:35-39. http://dx.doi.org/10.1016/j.micpath.2012.11.005.
13. Higashi N, Gesser B, Kawana S, Thestrup-Pedersen K. 2001. Expression of IL-18 mRNA and secretion of IL-18 are reduced in monocytes from patients with atopic dermatitis. J Allergy Clin Immunol 108:607-614. http://dx.doi.org/10.1067/mai.2001.118601.
14. Yamanaka K, Tanaka M, Tsutsui H, Kupper TS, Asahi K, Okamura H, Nakanishi K, Suzuki M, Kayagaki N, Black RA, Miller DK, Nakashima K, Shimizu M, Mizutani H. 2000. Skin-specific caspase-1-transgenic mice show cutaneous apoptosis and pre-endotoxin shock condition with a high serum level of IL-18. J Immunol 165:997-1003. http://dx.doi.org/10.4049/jimmunol.165.2.997.
15. Fantuzzi G, Puren AJ, Harding MW, Livingston DJ, Dinarello CA. 1998. Interleukin-18 regulation of interferon gamma production and cell proliferation as shown in interleukin-1beta-converting enzyme (caspase-1)-deficient mice. Blood 91:2118-2125.
16. Lamkanfi M, Dixit VM. 2012. Inflammasomes and their roles in health and disease. Annu Rev Cell Dev Biol 28:137-161. http://dx.doi.org/10.1146/annurev-cellbio-101011-155745.
17. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J, Elliston KO, Ayala JM, Casano FJ, Chin J, Ding J-F, Egger LA, Gaffney EP, Limjuco G, Palyha OC, Raju SM, Rolando AM, Salley JP, Yamin TT, Lee TD, Shivey JE, MacCross M, Mumford RA, Schmidt JA, Tocci MJ. 1992. A novel heterodimeric cysteine protease is required for interleukin-1ß processing in monocytes. Nature 356:768-774. http://dx.doi.org/10.1038/356768a0.
18. Sahoo M, Ceballos-Olvera I, del Barrio L, Re F. 2011. Role of the inflammasome, IL-1ß, and IL-18 in bacterial infections. ScientificWorld-Journal 11:2037-2050. http://dx.doi.org/10.1100/2011/212680.
19. Wang R, Braughton KR, Kretschmer D, Bach T-HL, Queck SY, Li M, Kennedy AD, Dorward DW, Klebanoff SJ, Peschel A, DeLeo FR, Otto M. 2007. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 13:1510-1514. http://dx.doi.org/10.1038/nm1656.
20. Tsompanidou E, Denham EL, Becher D, de Jong A, Buist G, van Oosten M, Manson WL, Back JW, van Dijl JM, Dreisbach A. 2013. Distinct roles of phenol-soluble modulins in spreading of Staphylococcus aureus on wet surfaces. Appl Environ Microbiol 79:886-895. http://dx.doi.org/10.1128/AEM.03157-12.
21. Tsompanidou E, Sibbald MJJB, Chlebowicz MA, Dreisbach A, Back JW, van Dijl JM, Buist G, Denham EL. 2011. Requirement of the agr locus for colony spreading of Staphylococcus aureus. J Bacteriol 193:1267-1272. http://dx.doi.org/10.1128/JB.01276-10.
22. Periasamy S, Joo H-S, Duong AC, Bach T-HL, Tan VY, Chatterjee SS, Cheung GYC, Otto M. 2012. How Staphylococcus aureus biofilms develop their characteristic structure. Proc Natl Acad Sci U S A 109:1281-1286. http://dx.doi.org/10.1073/pnas.1115006109.
23. Schwartz K, Syed AK, Stephenson RE, Rickard AH, Boles BR. 2012. Functional amyloids composed of phenol soluble modulins stabilize Staphylococcus aureus biofilms. PLoS Pathog 8:e1002744. http://dx.doi.org/10.1371/journal.ppat.1002744.
24. Kretschmer D, Gleske A-K, Rautenberg M, Wang R, Köberle M, Bohn E, Schöneberg T, Rabiet M-J, Boulay F, Klebanoff SJ, van Kessel KA, van Strijp JA, Otto M, Peschel A. 2010. Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus. Cell Host Microbe 7:463-473. http://dx.doi.org/10.1016/j.chom.2010.05.012.
25. Surewaard BGJ, Nijland R, Spaan AN, Kruijtzer JAW, de Haas CJC, van Strijp JAG. 2012. Inactivation of staphylococcal phenol soluble modulins by serum lipoprotein particles. PLoS Pathog 8:e1002606. http://dx.doi.org/10.1371/journal.ppat.1002606.
26. Cogen AL, Yamasaki K, Sanchez KM, Dorschner RA, Lai Y, MacLeod DT, Torpey JW, Otto M, Nizet V, Kim JE, Gallo RL. 2010. Selective antimicrobial action is provided by phenol-soluble modulins derived from Staphylococcus epidermidis, a normal resident of the skin. J Invest Dermatol 130:192-200. http://dx.doi.org/10.1038/jid.2009.243.
27. Joo HS, Cheung GYC, Otto M. 2011. Antimicrobial activity of community-associated methicillin-resistant Staphylococcus aureus is caused by phenol-soluble modulin derivatives. J Biol Chem 286:8933-8940. http://dx.doi.org/10.1074/jbc.M111.221382.
28. Gonzalez DJ, Okumura CY, Hollands A, Kersten R, Akong-Moore K, Pence MA, Malone CL, Derieux J, Moore BS, Horswill AR, Dixon JE, Dorrestein PC, Nizet V. 2012. Novel phenol-soluble modulin derivatives in community-associated methicillin-resistant Staphylococcus aureus identified through imaging mass spectrometry. J Biol Chem 287:13889-13898. http://dx.doi.org/10.1074/jbc.M112.349860.
29. Mehlin C, Headley CM, Klebanoff SJ. 1999. An inflammatory polypeptide complex from Staphylococcus epidermidis: isolation and characterization. J Exp Med 189:907-918. http://dx.doi.org/10.1084/jem.189.6.907.
30. Donvito B, Etienne J, Denoroy L, Greenland T, Benito Y, Vandenesch F. 1997. Synergistic hemolytic activity of Staphylococcus lugdunensis is mediated by three peptides encoded by a non-agr genetic locus. Infect Immun 65:95-100.
31. Wanke I, Skabytska Y, Kraft B, Peschel A, Biedermann T, Schittek B. 2013. Staphylococcus aureus skin colonization is promoted by barrier disruption and leads to local inflammation. Exp Dermatol 22:153-155. http://dx.doi.org/10.1111/exd.12083.
32. Boles BR, Thoendel M, Roth AJ, Horswill AR. 2010. Identification of genes involved in polysaccharide-independent Staphylococcus aureus biofilm formation. PLoS One 5:e10146. http://dx.doi.org/10.1371/journal.pone.0010146.
33. Schwartz K, Sekedat MD, Syed AK, O'Hara B, Payne DE, Lamb A, Boles BR. 2014. The AgrD N-terminal leader peptide of Staphylococcus aureus has cytolytic and amyloidogenic properties. Infect Immun 82:3837-3844. http://dx.doi.org/10.1128/IAI.02111-14.
34. Kebaier C, Chamberland RR, Allen IC, Gao X, Broglie PM, Hall JD, Jania C, Doerschuk CM, Tilley SL, Duncan JA. 2012. Staphylococcus aureus α-hemolysin mediates virulence in a murine model of severe pneumonia through activation of the NLRP3 inflammasome. J Infect Dis 205:807-817. http://dx.doi.org/10.1093/infdis/jir846.
35. Kahlenberg JM, Kaplan MJ. 2013. Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease. J Immunol 191:4895-4901. http://dx.doi.org/10.4049/jimmunol.1302005.
36. Muñoz-Planillo R, Franchi L, Miller LS, Núñez G. 2009. A critical role for hemolysins and bacterial lipoproteins in Staphylococcus aureus-induced activation of the Nlrp3 inflammasome. J Immunol 183:3942-3948. http://dx.doi.org/10.4049/jimmunol.0900729.
37. Dai X, Sayama K, Tohyama M, Shirakata Y, Hanakawa Y, Tokumaru S, Yang L, Hirakawa S, Hashimoto K. 2011. Mite allergen is a danger signal for the skin via activation of inflammasome in keratinocytes. J Allergy Clin Immunol 127:806-814.e1-4. http://dx.doi.org/10.1016/j.jaci.2010.12.006.
38. Sollberger G, Strittmatter GE, Grossi S, Garstkiewicz M, Auf dem Keller U, French LE, Beer H-D. 2015. Caspase-1 activity is required for UVB-induced apoptosis of human keratinocytes. J Investig Dermatol 135:1395-1404. http://dx.doi.org/10.1038/jid.2014.551.
39. Akeda T, Yamanaka K, Tsuda K, Omoto Y, Gabazza EC, Mizutani H. 2014. CD8+ T cell granzyme B activates keratinocyte endogenous IL-18. Arch Dermatol Res 306:125-130. http://dx.doi.org/10.1007/s00403-013-1382-1.
40. Inoue Y, Aihara M, Kirino M, Harada I, Komori-Yamaguchi J, Yamaguchi Y, Nagashima Y, Ikezawa Z. 2011. Interleukin-18 is elevated in the horny layer in patients with atopic dermatitis and is associated with Staphylococcus aureus colonization. Br J Dermatol 164:560-567. http://dx.doi.org/10.1111/j.1365-2133.2010.10145.x.
41. Niebuhr M, Baumert K, Heratizadeh A, Satzger I, Werfel T. 2014. Impaired NLRP3 inflammasome expression and function in atopic dermatitis due to Th2 milieu. Allergy 69:1058-1067. http://dx.doi.org/10.1111/all.12428.
42. Puxeddu I, Italiani P, Giungato P, Pratesi F, Panza F, Bartaloni D, Rocchi V, Del Corso I, Boraschi D, Migliorini P. 2013. Free IL-18 and IL-33 cytokines in chronic spontaneous urticaria. Cytokine 61:741-743. http://dx.doi.org/10.1016/j.cyto.2013.01.015.
43. Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D. 1999. Cutting edge: recognition of gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 163:1-5.
44. Nakamura Y, Oscherwitz J, Cease KB, Chan SM, Muñoz-Planillo R, Hasegawa M, Villaruz AE, Cheung GYC, McGavin MJ, Travers JB, Otto M, Inohara N, Núñez G. 2013. Staphylococcus δ-toxin induces allergic skin disease by activating mast cells. Nature 503:397-401. http://dx.doi.org/10.1038/nature12655.
45. Wozniacka A, Lesiak A, Boncela J, Smolarczyk K, McCauliffe DP, Sysa-Jedrzejowska A. 2008. The influence of antimalarial treatment on IL-1beta, IL-6 and TNF-alpha mRNA expression on UVB-irradiated skin in systemic lupus erythematosus. Br J Dermatol 159:1124-1130. http://dx.doi.org/10.1111/j.1365-2133.2008.08804.x.
46. Chen Y, Lind Enoksson S, Johansson C, Karlsson MA, Lundeberg L, Nilsson G, Scheynius A, Karlsson MCI. 2011. The expression of BAFF, APRIL and TWEAK is altered in eczema skin but not in the circulation of atopic and seborrheic eczema patients. PLoS One 6:e22202. http://dx.doi.org/10.1371/journal.pone.0022202.
47. Kiedrowski MR, Kavanaugh JS, Malone CL, Mootz JM, Voyich JM, Smeltzer MS, Bayles KW, Horswill AR. 2011. Nuclease modulates biofilm formation in community-associated methicillin-resistant Staphylococcus aureus. PLoS One 6:e26714. http://dx.doi.org/10.1371/journal.pone.0026714.